Esperion Therapeutics Inc (ESPR.OQ)

ESPR.OQ on NASDAQ Stock Exchange Global Market

15.59USD
29 Aug 2014
Price Change (% chg)

$0.05 (+0.32%)
Prev Close
$15.54
Open
$15.58
Day's High
$15.72
Day's Low
$15.58
Volume
3,339
Avg. Vol
6,946
52-wk High
$19.52
52-wk Low
$10.90

ESPR.OQ

Chart for ESPR.OQ

About

Esperion Therapeutics Inc is a United States-based biopharmaceutical company focused on the research, development and commercialization of therapies for the treatment of patients with elevated levels of low-density lipoprotein cholesterol (LDL-C) and other cardiometabolic risk factors. The Company has focused its initial drug... (more)

Overall

Beta: --
Market Cap (Mil.): $240.79
Shares Outstanding (Mil.): 15.44
Dividend: --
Yield (%): --

Financials

  ESPR.OQ Industry Sector
P/E (TTM): -- 153.62 33.23
EPS (TTM): -2.08 -- --
ROI: -83.52 -3.27 17.21
ROE: -975.25 -7.88 18.01
Search Stocks

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Ford Investor Services, Inc.
$12.00
Provider: ValuEngine, Inc.
$25.00
Provider: Thomson Reuters StreetEvents
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks